An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease (Q36778895)

16 August 2017

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

16 August 2017

0 references

0 references

1 reference

1 reference

10

0 references

Robert S. Langer, Jr.

12

object named as

Robert Langer

1 reference

16 August 2017

11

Giovanni Traverso

1 reference

16 August 2017

Sufeng Zhang

1

1 reference

16 August 2017

Joerg Ermann

2

1 reference

16 August 2017

Marc D Succi

3

1 reference

16 August 2017

Allen Zhou

4

1 reference

16 August 2017

Matthew J Hamilton

5

1 reference

16 August 2017

Bonnie Cao

6

1 reference

16 August 2017

Joshua R Korzenik

7

1 reference

16 August 2017

Jonathan N Glickman

8

1 reference

16 August 2017

Praveen K Vemula

9

1 reference

16 August 2017

Jeffrey M Karp

13

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

Science Translational Medicine

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

300

1 reference

16 August 2017

300ra128

1 reference

describes a project that uses

16 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4825054/fullTextXML

inferred from PubMed Central ID database lookup

cites work

A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

The impact of the extracellular matrix on inflammation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Defensins and inflammation: the role of defensins in inflammatory bowel disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Binding of sialyl Lewis X antigen to lectin-like receptors on NK cells induces cytotoxicity and tyrosine phosphorylation of a 17-kDa protein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Enhanced adhesion of ligand-conjugated biodegradable particles to colitic venules

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Predictors of medication adherence in inflammatory bowel disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4825054

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease

5 September 2018

1 reference

12 December 2020

Modified low density lipoprotein enhances the secretion of bile salt-stimulated cholesterol esterase by human monocyte-macrophages. species-specific difference in macrophage cholesteryl ester hydrolase

1 reference

12 December 2020

Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein

1 reference

12 December 2020

Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2

1 reference

12 December 2020

On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease

1 reference

12 December 2020

Macrophage Cultures: An Extracellular Esterase

1 reference

12 December 2020

Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD

1 reference

12 December 2020

Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey

1 reference

12 December 2020

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

1 reference

12 December 2020

Interactions between chitosan-modified particles and mucin-coated surfaces

1 reference

12 December 2020

The effect of dexamethasone treatment on murine colitis

1 reference

12 December 2020

10.1126/SCITRANSLMED.AAA5657

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

26268315

1 reference